Ultragenyx Pharmaceutical Inc. ($RARE)
Filing Information
| Accession Number | 0001193125-26-208632 |
|---|---|
| Form Type | 4 |
| Filing Date | May 6, 2026 |
| Document | View SEC Filing |
Transactions
1
Total Shares
344
Total Value
$8,586.24
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP and Chief Medical Officer | Common Stock | โ | May 5, 2026 | Sale | 344 | $24.96 | $8,586.24 | 111,189 | Direct | โ | View Details |